Columnist Joe MacDonald learns to step back as his son with hemophilia tackles some of the hard lessons of becoming independent.

A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...

A therapy to boost the production of regulatory T-cells prevented inhibitor formation in a mouse model of hemophilia A, per a ...

As her sons with hemophilia step into their futures prepared for what comes, columnist Cazandra Campos-MacDonald is embracing ...

Columnist G Shellye Horowitz is looking for a new factor product after the one she was trying had disappointing results.

The FDA has extended its approval of Jivi to cover the therapy's use in children with hemophilia A ages 7 years and older.

Columnist G Shellye Horowitz argues for a new way of classifying hemophilia severity that takes both genotype and phenotype into account.

Preventive treatment options that don't involve the use of FVIII or FIX are needed for patients who develop inhibitors, ...

Columnist Jennifer Lynne interviews 75-year-old Chip Hailey about his life leading up to receiving gene therapy for hemophilia B.

Columnist Alliah Czarielle notes how her husband with hemophilia finds freedom by using mobility aids after an ankle bleed.